Federal Supply Schedule 36F79720D0191
Award Date
8/15/20
Last Date to Order
8/14/26
Federal Agency
Veterans Integrated Service Network 12
Awardee
Cosette Pharmaceuticals, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded Scpharmaceuticals Inc., a for-profit pharmaceutical company based in Lexington, MA, a Federal Supply Schedule (FSS) contract valued at $600,875.40. This multiple-award, indefinite-delivery, indefinite-quantity (IDIQ) contract, designated as FSS 65 IB, covers the provision of drugs, pharmaceuticals, and hematology-related products to VA facilities over a five-year period ending in November 2028. In...
The Department of Veterans Affairs (VA) has awarded Amag Pharmaceuticals, Inc. multiple contract vehicles to supply the drug bremelanotide, marketed as Vyleesi, through the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule (FSS) master contract. The first vehicle is a single-award $2.25 million Blanket Purchase Agreement (BPA) from the VA National Acquisition Center, with a base year and four option years through July 2021. The second is a multiple-award $111,172,590 FSS-61-IB...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Federal Supply Schedule (FSS) contract to Vistapharm, Inc., a for-profit manufacturer of pharmaceutical goods. The contract, with a potential value of $20,359,397, is under the VA's Veterans Integrated Service Network 12 and is part of the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract has a period of performance from September 30, 2017, to March 31, 2024, and does not utilize any...
The provided information describes a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Biocodex, Inc., a foreign-owned for-profit company. The contract, identified as 36F79720D0119, falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and has a ceiling value of $700,000.00. The contract was awarded on May 1, 2020, with an ultimate completion date of October 31, 2025. The contract aims to procure drugs, pharmaceuticals, and...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Federal Supply Schedule (FSS) contract (36F79723D0079) to Fennec Pharmaceuticals, Inc., a foreign-owned, for-profit pharmaceutical company. This multiple-award contract has a ceiling value of $1,500,000 and a period of performance through February 29, 2028. It covers the provision of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 IB, intended to ensure VA medical centers and...
The contract is a Federal Supply Schedule (FSS) awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Eyevance Pharmaceuticals LLC, a foreign-owned for-profit manufacturer. The FSS contract is under Schedule 65 IB for Drugs, Pharmaceuticals, & Hematology Related Products, with a potential value of $450,000 and a period of performance through December 14, 2024. The contract aims to procure a range of pharmaceutical and drug products from the vendor. As an FSS...
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA) to Apotex Corp., provides for the delivery of 65 I B, Drugs, Pharmaceuticals, & Hematology Related Products. The contract has a ceiling value of $23,375,390.00 and a period of performance running from September 15, 2024 through September 14, 2029. As a Federal Supply Schedule (FSS) contract, this is a multiple award vehicle that allows federal agencies to procure the specified pharmaceutical and related...
The provided information details a Federal Supply Schedule (FSS) contract award to Aveo Pharmaceuticals, Inc. by the U.S. Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The $45,580,967.00 ceiling value contract has an ultimate completion date of October 14, 2026. The contract aims to procure pharmaceutical and hematology-related products to support the VA's healthcare operations. As an FSS contract, it allows for the placement of task...
This Federal Supply Schedule (FSS) contract, awarded by the U.S. Department of Veterans Affairs (VA), provides Pharmaceuticals and Drugs (FSS-61-IB) to the agency's Veterans Integrated Service Network 12. The prime contractor, Avion Pharmaceuticals, LLC, was awarded this multiple-award contract with a ceiling value of $675,000.00 and a period of performance through December 31, 2025. The contracted products and services encompass a broad range of pharmaceutical and hematology-related items....
This Federal Supply Schedule (FSS) contract, awarded to First Nation Group LLC, a veteran-owned and service-disabled veteran-owned small business, provides drugs, pharmaceuticals, and hematology-related products to the Department of Veterans Affairs (VA) and its Veterans Integrated Service Network 12 (VISN 12). The $225,000.00 contract has a performance period from September 15, 2024, to September 14, 2029. The price list includes a variety of pharmaceutical products, such as Cyclobenzaprine HCL...